Provided by Tiger Trade Technology Pte. Ltd.

California Resources

57.64
+1.853.32%
Pre-market: 57.00-0.6400-1.11%08:02 EDT
Volume:863.13K
Turnover:49.65M
Market Cap:5.11B
PE:-41.06
High:58.01
Open:56.50
Low:56.45
Close:55.79
52wk High:71.98
52wk Low:43.25
Shares:88.60M
Float Shares:83.56M
Volume Ratio:0.84
T/O Rate:1.03%
Dividend:1.60
Dividend Rate:2.78%
EPS(TTM):-1.4038
EPS(LYR):4.15
ROE:-3.55%
ROA:0.24%
PB:1.50
PE(LYR):13.89

Loading ...

CytomX Therapeutics Announces Q1 2026 Financial Results and Provides Business Update

GlobeNewswire
·
May 08

California Resources (CRC) Posts US$711m Q1 Loss Challenging Margin Improvement Narrative

Simply Wall St.
·
May 07

California Resources Corp Signals Stronger Earnings Momentum

TIPRANKS
·
May 07

Revolution Medicines Reports First Quarter 2026 Financial Results and Update on Corporate Progress

GlobeNewswire
·
May 07

Rhythm Biosciences’ ColoSTAT Test Gains Early Clinical Traction in Underserved CRC Patients

TIPRANKS
·
May 06

California Resources Highlights Strategic Progress and Shareholder Approvals

TIPRANKS
·
May 06

Analysts Offer Insights on Energy Companies: Gulfport Energy (GPOR) and California Resources Corp (CRC)

TIPRANKS
·
May 06

California Resources forecasts 2026 carbon management capital USD 12 million-USD 20 million

Reuters
·
May 06

California Resources 1Q26 adjusted EBITDAX rises to $304 million; net production totals 154 Mboe/d

Reuters
·
May 06

California Resources Q1 adjusted EPS tops expectations

Reuters
·
May 06

California Resources Q1 Adj. EPS $0.88 Beats $0.85 Estimate, Sales $119.000M Miss $936.631M Estimate

Benzinga Earnings
·
May 06

BRIEF-California Resources Q1 Adjusted EPS USD 0.88 Vs. IBES Estimate USD 0.85

Reuters
·
May 06

California Resources Corp - Increases 2026 Berry Merger Annual Synergy Target Midpoint by 12% to $90-$100 Mln

THOMSON REUTERS
·
May 06

California Resources Q1 EPS USD -8.02

THOMSON REUTERS
·
May 06

Press Release: California Resources Corporation Reports First Quarter 2026 Financial and Operating Results

Dow Jones
·
May 06

Carbon Terravault Provides First Quarter 2026 Update

THOMSON REUTERS
·
May 06

D3 Bio Presents KRAS Pipeline Updates at AACR 2026; Elisrasib (D3S-001), a Next-Generation KRAS G12C Inhibitor, Shows Strong Phase 2 Efficacy Across Multiple Tumor Types

prnewswire
·
Apr 30

Earning Preview: California Resources revenue is expected to increase by 8.71%, and institutional views are bullish

Earnings Agent
·
Apr 28

Erasca Announces Positive Preliminary Phase 1 Dose Escalation Data for Potentially Best-in-Class Pan-RAS Molecular Glue ERAS-0015 in KRAS-Mutant Solid Tumors

GlobeNewswire
·
Apr 28

Analyst Initiates Buy on Muza Developer, Citing Promising MSS CRC Data, Clear Registrational Path, and Broader Expansion Upside Despite Cash Constraints

TIPRANKS
·
Apr 27